Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 3, 2008, Pages 230-239

  Alvarez, L ^a,b   Lifschitz, A ^a,b   Entrocasso, C ^c   Manazza, J ^c   Mottier, L ^a,b   Borda, B ^c   Virkel, G ^a,b   Lanusse, C ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; IVERMECTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LAMB; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NEMATODIASIS; NONHUMAN; NONPARAMETRIC TEST; PARAMETRIC TEST; PRIORITY JOURNAL;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HALF-LIFE; IVERMECTIN; METABOLIC CLEARANCE RATE; NEMATODE INFECTIONS; SHEEP; SHEEP DISEASES; TISSUE DISTRIBUTION;

NEMATODA; OVIS ARIES; VERMES;

EID: 43549116781     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00953.x     Document Type: Article

References (55)

1. Alvarez, L., Sánchez, S. Lanusse, C. (1999) In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. Journal of Veterinary Pharmacology and Therapeutics, 22, 77 86.
2. Alvinerie, M., Sutra, J.F. Galtier, P. (1993) Ivermectin in goat milk after subcutaneous injection. Veterinary Research, 24, 417 421.
3. Anderson, N., Martin, P.J. Jarret, R.G. (1988) Mixtures of anthelmintics: a strategy against resistance. Australian Veterinary Journal, 65, 62 64.
4. Balayssac, D., Authier, N., Cayre, A. Coudore, F. (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicology Letters, 156, 319 329.
5. Benchaoui, H.A. McKellar, Q.A. (1996) Interaction between fenbendazole and piperonyl butoxide: pharmacokinetic and pharmacodynamic implications. The Journal of Pharmacy and Pharmacology, 48, 753 759.
6. Benz, G.W., Roncalli, R.A. Gross, S.J. (1989) Use of ivermectin in cattle, sheep, goats and swine. In Ivermectin and Abamectin. Ed. Campbell, W.C., pp. 215 229. Springer, New York.
7. Bogan, J. McKellar, Q. (1988) The pharmacodynamics of ivermectin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics, 11, 260 268.
8. Campbell, W. (1990) Benzimidazoles: veterinary uses. Parasitology Today, 6, 130 133.
9. Chiu, S.H., Green, M.L., Baylis, F.P., Eline, D., Rosegay, A., Meriwether, H. Jacob, T.A. (1990) Absorption tissue distribution and excretion of tritium-labelled ivermectin in cattle sheep and rats. Journal of Agricultural and Food Chemistry, 38, 2072 2078.
10. Cromie, L., Ferry, M., Couper, A., Fields, C. Taylor, S.M. (2006) Pharmacokinetics of a novel closantel/ivermectin injection in cattle. Journal of Veterinary Pharmacology and Therapeutics, 29, 205 211.
11. De Montigny, P., Shim, J. Pivinichny, J. (1990) Liquid chromatographic determination of ivermectin with trifluoro-acetic anhydride and N-methylimidazole as the derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis, 8, 507 511.
12. Delatour, P., Garnier, E., Benoit, E. Caude, I. (1991) Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Research in Veterinary Science, 50, 134 138.
13. Didier, A. Loor, F. (1996) The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anti-Cancer Drugs, 7, 745 751.
14. Dupuy, J., Lespine, A. Alvinerie, M. (2006) Influence of anthelmintic drugs on P-glycoprotein transport activity in mdr 1-LLC-PK1 cells. Journal of Veterinary Pharmacology and Therapeutics, 26, 109.
15. Entrocasso, C., Alvarez, L., Manazza, J., Lifschitz, A., Borda, B., Virkel, G., Mottier, L. Lanusse, C. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with multiple resistant nematodes. Veterinary Parasitology, in press.
16. Feng, X.P., Hayashi, J., Beech, R.N. Prichard, R. (2002) Study of the nematode putative GABA type-A receptor subunits: evidence for modulation by ivermectin. Journal of Neurochemistry, 83, 870 878.
17. Galtier, P., Alvinerie, M. Delatour, P. (1986) In vitro sulphoxidation of albendazole by ovine liver microsomes. American Journal of Veterinary Research, 47, 447 450.
18. Galtier, P., Alvinerie, M., Steimer, J., Francheteau, P., Plusquellec, Y. Houin, G. (1991) Simultaneous pharmacokinetics modelling of a drug and two metabolites: application to albendazole in sheep. Journal of Pharmaceutical Sciences, 80, 3 10.
19. Gerlach, J., Endicott, J., Juranka, P., Henderson, G., Sarangi, F., Deuchars, K. Ling, V. (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggest a model for multidrug resistance. Nature, 324, 485 489.
20. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn. pp. 45 109. Marcel Dekker, NewYork.
21. Hennessy, D.R., Steel, J.W., Lacey, E., Eagleson, G.K. Prichard, R.K. (1989) The disposition of albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 12, 421 429.
22. Imperiale, F., Lifschitz, A., Sallovitz, J., Virkel, G. Lanusse, C. (2004) Comparative depletion of ivermectin and moxidectin milk residues in dairy sheep after oral and subcutaneous administration. Journal of Dairy Research, 71, 427 433.
23. Kaplan, R. (2004) Drug resistance in nematodes of veterinary importance: a status report. Trends in Parasitology, 20, 477 481.
24. Lacey, E. (1990) Mode of action of benzimidazoles. Parasitology Today, 6, 112 115.
25. Laffont, C.M., Toutain, P.L., Alvinerie, M. Bousquet-Melou, A. (2002) Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metabolism and Disposition, 30, 626 630.
26. Lanusse, C. Prichard, R. (1992) Effects of methimazole on the kinetics of netobimin metabolites in cattle. Xenobiotica, 22, 115 123.
27. Lanusse, C., Gascon, L. Prichard, R. (1993) Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics. Journal of Veterinary Pharmacology and Therapeutics, 16, 38 47.
28. Lanusse, C., Gascon, L. Prichard, R. (1995) Comparative plasma disposition kinetics of albendazole, fenbendazole, oxfendazole and their metabolites in adult sheep. Journal of Veterinary Pharmacology and Therapeutics, 18, 196 203.
29. Lanusse, C., Lifschitz, A., Virkel, G., Alvarez, L., Sanchez, S., Sutra, J.F., Galtier, P. Alvinerie, M. (1997) Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 20, 91 99.
30. Lespine, A., Dupuy, J., Orlowski, S., Nagy, T., Glavinas, H., Krajcsi, P. Alvinerie, M. (2006) Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chemico-Biological Interactions, 159, 169 179.
31. Lifschitz, A., Virkel, G., Pis, A., Imperiale, F., Sánchez, S., Alvarez, L., Kujanek, R. Lanusse, C. (1999) Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Veterinary Parasitology, 86, 203 215.
32. Lifschitz, A., Virkel, G., Sallovitz, J., Galtier, P., Alvinerie, M. Lanusse, C. (2000) Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle. Veterinary Parasitology, 87, 327 338.
33. Lifschitz, A., Virkel, G., Sallovitz, J., Pis, A., Imperiale, F. Lanusse, C. (2004) Loperamide modifies the tissue disposition kinetics of ivermectin in rats. Journal of Pharmacy and Pharmacology, 56, 61 67.
34. Marriner, S. Bogan, J. (1980) Pharmacokinetics of albendazole in sheep. American Journal of Veterinary Research, 41, 1126 1129.
35. Marriner, S., McKinnon, I. Bogan, J. (1987) The pharmacokinetics of ivermectin after the oral and subcutaneous administration to sheep and horses. Journal of Veterinary Pharmacology and Therapeutics, 10, 175 179.
36. McKellar, Q. Benchaoui, H. (1996) Avermectins and milbemycins. Journal of Veterinary Pharmacology and Therapeutics, 19, 331 351.
37. McKellar, Q. Scott, E. (1990) The benzimidazole anthelmintic agents - a review. Journal of Veterinary Pharmacology ad Therapeutics, 13, 223 247.
38. Merino, G., Alvarez, A., Prieto, J. Kim, R.B. (2002) The anthelmintic agent albendazole does not interact with P-glycoprotein. Drug Metabolism and Disposition, 30, 365 369.
39. Merino, G., Molina, A., García, J., Pulido, M., Prieto, J. Alvarez, A. (2003) Intestinal elimination of albendazole sulphoxide: pharmacokinetic effects of inhibitors. International Journal of Pharmaceutics, 263, 123 132.
40. Merino, G., Jonker, J.W., Wagenaar, E., Pulido, M., Molina, A.J., Alvarez, A. Schinkel, A. (2005) Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metabolism and Disposition, 33, 614 618.
41. Notari, R.E. (1987) Biopharmaceutics and Clinical Pharmacokinetics, 4th edn. pp. 45 128. Marcel Dekker, New York.
42. Perrier, D. Mayersohn, M. (1982) Non-compartmental determination of the steady-state volume of distribution for any mode of administration. Journal of Pharmaceutical Sciences, 71, 372 373.
43. Pouliot, J.F., L'Heureux, F., Liu, Z., Prichard, R. Georges, E. (1997) Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochemical Pharmacology, 53, 17 25.
44. Rawden, H., Kokwaro, G., Ward, S. Edwards, G. (2000) Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. British Journal of Clinical Pharmacology, 49, 313 322.
45. Redondo, P., Alvarez, A., Garcia, J., Larrodé, O., Merino, G. Prieto, J. (1999) Presystemic metabolism of albendazole: experimental evidence of an efflux process of albendazole sulphoxide to intestinal lumen. Drug Metabolism and Disposition, 27, 736 740.
46. Snyder, L.L., Kirkland, J. Glajch, J. (1997) Practical HPLC Method Development, 2nd edn, pp. 645 646. John Wiley & Sons, Inc., New York.
47. Souhaili-El Amri, H., Fargetton, X., Delatour, P. Batt, A. (1987) Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes. Xenobiotica, 17, 1159 1168.
48. Souhaili-El Amri, H., Mothe, O., Totis, M., Masson, C., Batt, A., Delatour, P. Siest, G. (1988) Albendazole sulfonation by rat liver cytochrome P-450c. The Journal of Pharmacology and Experimental Therapeutics, 246, 758 764.
49. Suzuki, H. Sugiyama, Y. (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from small intestine. European Journal of Pharmaceutical Sciences, 12, 3 12.
50. Szotáková, B., Baliharová, V., Lamka, J., Nožinová, E., Wsól, V., Velík, J., Machala, M., Neča, J., Souček, P., Šusová, S. Skálová, L. (2004) Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science, 76, 43 51.
51. Virkel, G., Lifschitz, A., Sallovitz, J., Pis, A. Lanusse, C. (2004) Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metabolism and Disposition, 32, 536 544.
52. Wolstenholme, A., Fairweather, I., Prichard, R., von Samson- Himmelstjerna, G. Sangster, V. (2004) Drug resistance in veterinary parasites. Trends in Parasitology, 20, 469 476.
53. Yates, D.M., Portillo, V. Wolstenholme, A.J. (2003) The avermectin receptors of Haemonchus contortus and Caenorhabditis elegans. International Journal for Parasitology, 33, 1183 1193.
54. Zeng, Z., Andrew, N., Woda, J., Halley, B., Crouch, L. Wang, R. (1996) Role of cytochrome P450 isoforms in the metabolism of abamectin and ivermectin in rats. Journal of Agricultural and Food Chemistry, 44, 3374 3378.
55. Zeng, Z., Andrew, N., Arison, B., Luffer-Atlas, D. Wang, R. (1998) Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica, 28, 313 321.